Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Inventory (2016 - 2024)

PAVmed has reported Inventory over the past 5 years, most recently at $687000.0 for Q2 2024.

  • For Q2 2024, Inventory changed N/A year-over-year to $687000.0; the TTM value through Jun 2024 reached $687000.0, changed N/A, while the annual FY2023 figure was $278000.0, 150.45% up from the prior year.
  • Inventory for Q2 2024 was $687000.0 at PAVmed, up from $410000.0 in the prior quarter.
  • Over five years, Inventory peaked at $687000.0 in Q2 2024 and troughed at $50000.0 in Q3 2021.
  • A 5-year average of $265166.7 and a median of $194500.0 in 2022 define the central range for Inventory.
  • On a YoY basis, Inventory climbed as much as 150.45% in 2023 and fell as far as 150.45% in 2023.
  • Year by year, Inventory stood at $55000.0 in 2020, then dropped by 9.09% to $50000.0 in 2021, then surged by 122.0% to $111000.0 in 2022, then soared by 150.45% to $278000.0 in 2023, then surged by 147.12% to $687000.0 in 2024.
  • Business Quant data shows Inventory for PAVM at $687000.0 in Q2 2024, $410000.0 in Q1 2024, and $278000.0 in Q4 2023.